Skip to content
Disclosery

ORBIMED ADVISORS LLC: AORT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on AORT, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 175,000 AORT shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 175,000 shares
    Change vs previous 13F +24,000 shares

    0.07% of the 13F portfolio, value $3,932,250.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 151,000 shares
    Change vs previous 13F not available

    0.12% of the 13F portfolio, value $5,529,620.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).